These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31756447)

  • 1. Low-dose docetaxel enhances the anti-tumour efficacy of a human umbilical vein endothelial cell vaccine.
    Zhou L; Lu M; Zhong W; Yang J; Yin Y; Li M; Li D; Zhang S; Xu M
    Eur J Pharm Sci; 2020 Jan; 142():105163. PubMed ID: 31756447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Human Umbilical Vein Endothelial Cell Vaccine and Docetaxel Generates Synergistic Anti-Breast Cancer Effects.
    Lu M; Yao Q; Liu H; Zhong W; Gao J; Si C; Zhou L; Zhang S; Xu M
    Cancer Biother Radiopharm; 2019 Sep; 34(7):464-471. PubMed ID: 31009240
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of in vivo anti-tumor activity of human umbilical vein endothelial cell vaccines prepared by various antigen forms.
    Zhou L; Si C; Li D; Lu M; Zhong W; Xie Z; Guo L; Zhang S; Xu M
    Eur J Pharm Sci; 2018 Mar; 114():228-237. PubMed ID: 29277666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Fixed Human Umbilical Vein Endothelial Cell Vaccine With 2 Tandem Repeats of Microbial HSP70 Peptide Epitope 407-426 As Adjuvant for Therapy of Hepatoma in Mice.
    Xu M; Zhou L; Zhang Y; Xie Z; Zhang J; Guo L; Wang C; Yang X
    J Immunother; 2015 Sep; 38(7):276-84. PubMed ID: 26261891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Antitumor Efficacy of Combined Vaccine Based on the Induced HUVECs and DC-CT26 Against Colorectal Carcinoma.
    Zhang Q; Xie C; Wang D; Yang Y; Liu H; Liu K; Zhao J; Chen X; Zhang X; Yang W; Li X; Tian F; Dong Z; Lu J
    Cells; 2019 May; 8(5):. PubMed ID: 31121964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontak reduces the immunosuppressive tumor environment and enhances successful therapeutic vaccination in HER-2/neu-tolerant mice.
    Gritzapis AD; Voutsas IF; Baxevanis CN
    Cancer Immunol Immunother; 2012 Mar; 61(3):397-407. PubMed ID: 21928125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion with human lung cancer cells elongates the life span of human umbilical endothelial cells and enhances the anti-tumor immunity.
    Mu X; Fang C; Zhou J; Xi Y; Zhang L; Wei Y; Yi T; Wu Y; Zhao X
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):111-23. PubMed ID: 26139353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-cell-secreted CXCL11 promoted CD8
    Gao Q; Wang S; Chen X; Cheng S; Zhang Z; Li F; Huang L; Yang Y; Zhou B; Yue D; Wang D; Cao L; Maimela NR; Zhang B; Yu J; Wang L; Zhang Y
    J Immunother Cancer; 2019 Feb; 7(1):42. PubMed ID: 30744691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the specific immunity of dendritic cell vaccine loading human umbilical vein endothelial cell antigen against U14 cervical cancer].
    Zhao J; Zhai JM; Lu J; Yang HY; Huang YT; Li S; Dong ZM; Zhang X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):196-200. PubMed ID: 19257979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced antitumor efficacy by combination treatment with a human umbilical vein endothelial cell vaccine and a tumor cell lysate-based vaccine.
    Xu M; Zhou L; Zhang P; Lu Y; Ge C; Yao W; Xing Y; Xiao W; Dong Y; Wu J; Cao R; Li T
    Tumour Biol; 2013 Oct; 34(5):3173-82. PubMed ID: 23771850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy for lung metastasis induced by the allogeneic bEnd3 vaccine in mice.
    Zhao J; Lu J; Zhou L; Zhao J; Dong Z
    Hum Vaccin Immunother; 2018 May; 14(5):1294-1304. PubMed ID: 29360423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant.
    Xu M; Xing Y; Zhou L; Yang X; Yao W; Xiao W; Ge C; Ma Y; Yang J; Wu J; Cao R; Li T; Liu J
    Tumour Biol; 2013 Jun; 34(3):1399-408. PubMed ID: 23456765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of tumors with human telomerase reverse transcriptase immortalized human umbilical vein endothelial cells.
    Mu X; Sang Y; Fang C; Shao B; Yang L; Yao K; Zhao X; Gou J; Wei Y; Yi T; Wu Y; Zhao X
    Int J Oncol; 2015 Nov; 47(5):1901-11. PubMed ID: 26398907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two tandem repeats of mHSP70
    Xu M; Zhang Y; Dong W; Jiang L; Zhang J; Yu P; Xie S; Zhou L
    Life Sci; 2018 May; 201():102-110. PubMed ID: 29572180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial HSP70 peptide epitope 407-426 as adjuvant in tumor-derived autophagosome vaccine therapy of mouse lung cancer.
    Li J; Xing Y; Zhou Z; Yao W; Cao R; Li T; Xu M; Wu J
    Tumour Biol; 2016 Nov; 37(11):15097-15105. PubMed ID: 27662838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
    Baghban Rahimi S; Mohebbi A; Vakilzadeh G; Biglari P; Razeghi Jahromi S; Mohebi SR; Shirian S; Gorji A; Ghaemi A
    Arch Virol; 2018 Mar; 163(3):587-597. PubMed ID: 29149434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human umbilical vein endothelial cell vaccine suppresses the angiogenesis of esophageal squamous cell carcinoma in a humanized mouse model.
    Liu H; Zhao J; Yang Y; Jin G; Zhang X; Wang D; Xie C; Liu K; Chen X; Li X; Tian F; Dong Z; Lu J
    Oncol Rep; 2018 Nov; 40(5):3006-3014. PubMed ID: 30132560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy.
    Beziaud L; Boullerot L; Tran T; Mansi L; Marie-Joseph EL; Ravel P; Johannes L; Bayry J; Tartour E; Adotévi O
    Int J Cancer; 2018 Dec; 143(11):3008-3018. PubMed ID: 30183073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine.
    Karan D; Krieg AM; Lubaroff DM
    Int J Cancer; 2007 Oct; 121(7):1520-8. PubMed ID: 17565748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.